CNE000001BG9
CNE000001BG9
SHANDONG PHARMACEUTICAL GLASS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 12.13B EUR | 12.24B EUR | 12.29B EUR | 13.23B EUR |
Enterprise Value | 9.39B EUR | 10B EUR | 9.79B EUR | 12.19B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.58x | 23.63x | 24.78x | 25.52x |
Forward P/E | 15.9x | -- | -- | -- |
Price to Sales | 2.69x | 2.72x | 2.72x | 4x |
Price to Book | 1.42x | 1.43x | 1.47x | 1.59x |
EV/Revenue | 2.08x | 2.22x | 2.17x | 3.69x |
EV/EBITDA | 7.55x | 13.6x | 13.26x | 16.45x |
Price to FCF (P/FCF) | 35.96x | 33.77x | 40.35x | 46.45x |
EV/FCF | 27.83x | 27.59x | 32.16x | 42.81x |
FCF Yield | 2.78% | 2.96% | 2.48% | 2.15% |